CD22(low)/Bcl-2(high) expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia

por Wintering, Astrid, Ishiyama, Kenichi, Tamaki, Stanley, Tamaki, Courtney, Fandel, Joshua, Ji, Lingyun, Wood, Brent L., Shah, Nirali N., Yuan, Constance M., O’Brien, Maureen M., Loh, Mignon L., Diaz-Flores, Ernesto
Publicado 2022

DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival

por Wiencke, J. K., Molinaro, Annette M., Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie W., Wrensch, Margaret, Hansen, Helen, McCoy, Lucie, Tang, Emily, Tamaki, Stan J., Tamaki, Courtney M., Nissen, Emily, Bracci, Paige, Salas, Lucas A., Koestler, Devin C., Christensen, Brock C., Zhang, Ze, Kelsey, Karl T.
Publicado 2022

Intestinal inflammation alters the antigen-specific immune response to a skin commensal

por Merana, Geil R., Dwyer, Laura R., Dhariwala, Miqdad O., Weckel, Antonin, Gonzalez, Jeanmarie R., Okoro, Joy N., Cohen, Jarish N., Tamaki, Courtney M., Han, Jungmin, Tasoff, Preston, Palacios-Calderon, Yasmin, Ha, Connie W.Y., Lynch, Susan V., Segre, Julia A., Kong, Heidi H., Kattah, Michael G., Ma, Averil, Scharschmidt, Tiffany C.
Publicado 2022

The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

por Dong, Shen, Hiam-Galvez, Kamir J., Mowery, Cody T., Herold, Kevan C., Gitelman, Stephen E., Esensten, Jonathan H., Liu, Weihong, Lares, Angela P., Leinbach, Ashley S., Lee, Michael, Nguyen, Vinh, Tamaki, Stanley J., Tamaki, Whitney, Tamaki, Courtney M., Mehdizadeh, Morvarid, Putnam, Amy L., Spitzer, Matthew H., Ye, Chun Jimmie, Tang, Qizhi, Bluestone, Jeffrey A.
Publicado 2021